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Abstract
Intravascular-thrombosis and extravascular-lipid-deposit are the two key pathogenic events considered to interrupt
intraosseous blood supply during development of steroid-associated osteonecrosis (ON). However, there are no clinically
employed agents capable of simultaneously targeting these two key pathogenic events. The present experimental study
demonstrated that constitutional flavonoid glycosides derived from herb Epimedium (EF, composed of seven flavonoid
compounds with common stem nuclear) exerted dose-dependent effect on inhibition of both thrombosis and lipid-
deposition and accordingly reducing incidence of steroid-associated ON in rabbits, which was not via direct action by
themselves rather by their common metabolite on potential cellular targets involved in the two pathogenic pathways. The
underlying mechanism could be explained by counteracting endothelium injury and excessive adipogenesis. These findings
encourage designing clinical trials to investigate potential of EF in prevention of steroid-associated ON.
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Introduction
Steroids are indicated for serious infectious diseases such as
Severe Acute Respiratory Syndrome (SARS) and Acquired
Immure Deficiency Syndrome, or for chronic autoimmune disease
such as Systemic Lupus Erythematosus and Rheumatoid Arthritis.
However, steroid-associated osteonecrosis (ON) frequently occurs.
It is highly desirable to develop agents which could prevent ON
occurrence due to its generally poor surgical prognosis [1–3].
The etiopathogenesis of steroid-associated ON has been
recently explained by both intravascular thrombosis induced
occlusion and extravascular lipid-deposit induced pressure, leading
to impairment of intra-osseous blood supply [1,3–4]. Endothelium
injury, which predisposes to both hypercoagulation and hypofi-
brinolysis, has consistently presented itself in the intravascular
events [5]; while elevated adipogenesis [6] is involved in
extravascular events [7]. Although it has been experimentally
confirmed that a combined administration of an anticoagulant
with a lipid-lowering agent may help prevent steroid-associated
ON [8], the ideal strategy would be simultaneously target both
intravascular thrombosis and extravascular lipid deposition for
preventing steroid-associated ON development [4].
The authors’ clinical epidemiological data showed that a lower
prevalence (5–6%) of ON was found in patients recovered from
SARS frequently prescribed with crude extract of flavonoids rich
‘‘BoneStrengthening Herb’’ Epimedium duringtheirrehabilitation in
southernChina[9–10],whereasa higherprevalence (32.7%)[11] of
ON was found in those seldom prescribed with crude extract of
Epimedium in northern China. Recently, using small scale laboratory
isolation procedure, ‘‘Bone Strengthening Herb’’ Epimedium derived
flavonoids showed beneficial effect on prevention of steroid-
associated ON with inhibition of both intravascular thrombosis
and extravascular lipid-deposition in our established rabbit model
with a single dose study design [7,12]. Now, a simplified procedure
for isolating flavonoids from herbal Epimedium to meet requirement
of large scale production has been established (International
Application Number: PCT/CN2008/000165 issued by
World Intellectual Property Organization), which generates
seven major flavonoid compounds with common stem nuclear
characterized by high performance liquid chromatography (HPLC)
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isoflavones with common stem nuclei may be intestinally metab-
olized to Equal for acting on pharmacological targets [13], we
predicted that all the seven flavonoid glycosides with common stem
nuclei in the EF could be finally intestinally metabolized to a
uniform molecule detected in serum.
Up to date, there were no available studies addressing dose-effect
pattern and active substance basis of EF obtained from the
simplified isolation procedure. Accordingly, the following two
specific experiments were designed in the present study. Study I
was to use our established rabbit model [7] to examine the effect of
the EF in different dosage on haematological indices for
intravascular thrombosis and extravascular lipid-deposition, as well
as histopathological indices of ON lesion, intravascular thrombosis
and extravascular lipid-deposition, respectively. Both prototype and
metabolite of EF in serum were also examined by high performance
liquid chromatography (HPLC)/ultra-violet (UV)/electrospray
ionization-ion trap mass spectrometry (MS). Study II was to use
human umbilical vein endothelial cell model and 3T3-L1
preadipocyte model in vitro to detect the prevention effect of
Icaritin, the detectable metabolite of the EF, as well as those seven
prototype flavonoid glycosides, on endotoxin-induced endothelial
cell damage and steroid-induced lipid deposition, respectively.
Materials and Methods
Study I
Animal, Group and Treatment. One hundred and twelve
male 28-week-old New-Zealand white rabbits with body weight of
4,5 kg were housed at the Laboratary Animal Service Center of
Prince of Wales Hospital, the affiliated hospital of the Chinese
University of Hong Kong. The animals received a standard
laboratory diet and water ad lititum. The experimental protocol was
approved by Animal Experiment Ethics Committee of authros’
institution in Hong Kong (Ref No. 04/038/MIS). Based on our
established protocol for inducing steroid-associated ON [7], all the
rabbits were intravenously injected with 10 mg. kg
21 of
Lippolysaccharide (LPS; Escherichia coli 0111:B4, Sigma-
Aldrich, Inc. USA) on day 0 (week 0). 24 hours later, three
injections of 20 mg. kg
21 of Methylprednisolone (MPS;
Pharmacia & Upjohn, USA) were given intramuscularly at a
time interval of 24 hours. Simultaneously, the rabbits were divided
into 4 groups for the following daily oral administration: low dose
EF group (L-EF; n=28; 10 mg. kg
21. day
21), middle dose EF
group (M-EF; n=28; 20 mg. kg
21. day
21), high dose EF group
(H-EF; n=28; 40 mg. kg
21. day
21), and control group received
corresponding vehicle of EF daily (CON; n=28).
Figure 1. Seven major flavonoid compounds are identified in Epimedium-derived Flavonoids (EF). The common structure is 8-
prenylkaempferol. R1 and R2 are substituted by glucose, rhamnose, or xylose, and R3 is replaced by methyl.
doi:10.1371/journal.pone.0006419.g001
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immediately before LPS injection), 1 and 2 post induction, 5 ml
blood sample was collected. Plasma and serum were prepared for
evaluating endothelium damage index TM (Thrombomodulin)
using established protocols [7,14–15] and detection of both
prototype and metabolite of EF, respectively. In addition, serum
hepatocyte injure indices, including Alanine aminitransperase
(ALT) and Aspartate aminotransferase (AST), were examined for
evaluating potential hepatocyte toxicity of EF. Marrow sample
from iliac crest was also obtained for local evaluation of adipogenic
potential index of mesenchymal stem cell (Adipocyte Positvie
Colonies) [16]. On the other hand, dynamic-contrast-enhanced
MRI was performed on proximal femur for intra-osseous perfusion
function index (PEP, i.e. ‘peak enhancement percentage’) before
sacrifice at baseline, week 1, and week 2 post-induction, using a
bolus of dimeglumin gadopentetate (Magnevist; Schering, Berlin,
Germany) with our established protocol [7,12,16].
Serum Examination for either Prototype or Metabolite of EF:
Serum was obtained by centrifugation at 4500 revolutions per
minute (rpm) for 15 min and stored at 280uC before analysis. All
serum samples were thawed at room temperature. Analytes were
extracted from 1 ml serum aliquots by liquid-liquid partition using
water-saturated ethyl acetate. The ethyl acetate partitions were
dried by gently blowing with nitrogen (N2) gas at room
temperature. The residues were re-dissolved in 60% MeOH-
H2O for injection into performance liquid chromatography-
tandem mass spectrometry (HPLC-MS/MS) analysis, using an
HPLC system coupled with a UV-DAD (Ultra-Violet) system and
an ESI ion trap mass spectrometry. LC separation was conducted
using an Agilent Series 1100HPLC system and a C18 reversed-
phase (RP) column (5 mm, 4.6 mm6250 mm; Shimadzu, Japan)
and 75% MeOH-H2O as mobile phase at a flow rate of 1.0 ml/
min. MS analysis was performed using an Esquire 2000 ESI ion
trap mass spectrometer (Bruker, USA) equipped with Esquire
control software. Mass spectra were acquired and processed using
the software provided by the manufacturer. The positive ion mode
and MS/MS analysis were selected, working under the following
conditions: Capillary Voltage=4 kV; Capillary Tempera-
ture=300uC; Nebulizer Gas Pressure=30 psi; Drying Gas Flow
Rate=10 L/min. The scan range was m/z 50–1500, the
maximum injection time was 50 ms, and two scan events were
prescribed to run sequentially in the mass spectrometer.
Marrow Examination for Adipogenic Potential: Bone marrow
was aspirated sterilely from either side of bilateral iliac crests of
each rabbit using a pre-heparinized flexible plastic tube affixed to
a 10-ml syringe containing 1 ml of heparin solution (1000 U/ml).
Marrow mononuclear cells (MNCs) were isolated by discontinued
gradient centrifugation on Ficoll (Density=1.074 g/ml) at 1050 g
for 25 minutes at room temperature. The isolated MNCs were
cultured for mesenchymal stem cell (MSC) in basal medium,
containing Dulbecco’s modified Eagle’s medium (DMEM), 10%
fetal bovine serum (FBS), 1% mixture of penicillin, streptomycin
and neomycin (Invitrogen 120 Corporation, Carlsbad, USA),
which were incubated at 37uC, 5% humidified CO2. After three
days, the medium was changed and nonadherent hematopoietic
cells were discarded. Afterwards, the medium was changed once a
week in two weeks. Two weeks later, the cells were seeded at a
density of 5000 cells/cm
2 for culture in the basal medium until
80% confluence in one week. Thereafter, the basal medium was
repalced with an adipogenic medium (the basal medium
supplemented with 15% normal horse serum and 100 nM
dexamethasone) (Sigma, Demark) for culture in two weeks [17].
After 2 weeks in culture, the cells in vitro were stained with Oil red
O. The colonies cotaining adipocytes that are positive for Oil red
O were considered as adipocytic colonies. Percentage of
Adipocytic Colonies per Total Colony Number (Adipocyte
Positvie Colonies), as adipogenic potential index, was determined
microscopically. A colony is defined as a distinct group of more
than 16 cells and it represents the derect descedent of 1 MSC
present at culture start [18–19].
Post-euthanasia Evaluation. 4, 8 and 16 rabbits in each
group were sacrificed at week 0, 1 and 2 post induction,
respectively. The body weight of each rabbit before sacrifice was
documented. Survival condition throughout the experiment period
in each group was recorded.
Examination of ON Lesion: After sacrifice using overdose
Sodium Pentobarbitone, the decalcified proximal femoral samples
were embedded in Paraffin, cut into 6-mm-thick sections along the
coronal plane for histopathological examination by Hematoxylin
& Eosin (H&E) staining [7]. Identification of ON lesion was
performed using established criteria, i.e. diffuse presence of empty
lacunae or pyknotic nuclei of osteocytes in the trabeculae
accompanied by surrounding necrotic bone marrow [20–21].
Rabbit that had at least one ON lesion in the areas was considered
as ON
+, while that with no ON lesion was considered as ON
2.
ON Incidence was defined as numbers of ON
+ rabbits divided by
numbers of total rabbits in each group, and ON Extent was
defined as numbers of ON lesions per ON
+ rabbit [7,12].
Examination of Thrombotic Vessels Counts for Intravascular
Thrombosis: Fifteen successive slices in each dissected proximal 1/
3 part of bilateral femur samples of each rabbit were chosen for
summation of histopathological index of intravascular thrombosis,
i.e. Thrombotic Vessle Counts, usng a microscope imaging system
(Zeiss Aixoplan with Spot RT digital camera, Zeiss, Germany)
[7,12].
Examination of Fat Cell Area Fraction for Extravascular Lipid-
deposition: Fifteen successive slices in each dissected proximal 1/3
part of bilateral femur samples of each rabbit were calculated for
average of Fat Cell Area Fraction, a histopathological index of
extravascular lipid deposition, defined as total marrow fat cell area
normalized by total marrow tissue area in each slice. The marrow
fat cells with easily identified profile were quantified using a
microscope imaging system (Zeiss Aixoplan with Spot RT digital
camera, Zeiss, Germany) with image analysis software (ImageJ
1.32j, NIH, USA) [7,12]. Intravascular thrombosis index (Throm-
botic Vessle Counts), and extravascular lipid-deposition index (Fat
Cell Area Fraction) were also histo morphometrically quantified.
Study II
In Vitro Study using Human Umbilical Vein Endothelial
Cell Damage Model. Human Umbilical Vein Endothelial Cells
(HUVECs, SC-8000, ScienCell Research Laboratories, USA) were
maintained in commercialized Endothelial Cell Medium (SC-1001,
ScienCell Research Laboratories, USA). These HUVECs were
incubated in a humidified atmosphere containing 5% CO2 at 37uC
and passed every three days. HUVECs were cultured in 24-well
plates at a density of 1,2610
5/ml and allowed to grow to desired
confluence. The cells were incubated with LPS (Escherichia coli
0111:B4, Sigma-Aldrich, Inc. USA) at a concentration of 0.625 mg/
ml for 24 hours [22]. Before incubation with LPS, HUVECs were
pretreated for 24 hours with Icaritin (HPLC Purity.99%, semi-
synthesis by Shenzhen Research Institute of Tsinghua University,
China) at 0 M (indcution group), 10
216 M (low dose group),
10
214 M (middle dose group), 10
212 M (high dose group) and
parent compounds in EF (EF1 , EF7) at 10
214 M. The control
group was defined as non-LPS-incubated cells without Icaritin
pretreatment but dimethyl sulfoxide (DMSO). Icaritin and LPS was
dissolved using DMSO and the content of DMSO should never
Epimedium Prevents ON
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manufacture, supernate soluble TM was measured using
commercialized Human Thrombomodulin ELISA Kit (ab46508,
Abcam, UK). All experiments were performed in triplicate.
In Vitro Study using Preadipocyte Lipid Deposition
Model. NIH 3T3-L1 cells were grown in a phenol red-free
Dulbecco’s modified Eagle’s medium (DMEM/F-12) (Gibco, USA)
with 10% calf serum. Based on established adipogenic differentiation
protocol with specific medium [23], Icaritin at 0 M (indcution group),
10
216 M (low dose group), 10
214 M (middle dose group), 10
212 M
(high dose group) and parent compounds in EF (EF1 , EF7) at
10
214 M was added to the medium over the full course of
differentiation. The control group was defined as non-steroid-
incubated cells without Icaritin treatment but DMSO. Icaritin and
Dexamethasone was dissolved using DMSO and the content of
DMSO should never exceed 0.05% in all the groups. Medium was
changed every other day. One week later, the cells were washed with
phosphate-buffered saline (PBS) twice, and then stained with 0.6%
Oil Red O solution for 2 hours at room temperature. Stained Oil
Red O was eluted with isopropanol after the cells were washed, and
the optical density (OD) of the solution at 520 nmwasmeasured [24].
All experiments were performed in triplicate.
Statistics. The ON Incidence was compared using Fisher’s
exact probability test. The cross-sectional quantificational data were
expressed as Mean6SD, which were examined using Analysis of
Covariance (ANCOVA) with body weight as covariant variable for
eliminating its influence on the measurement results, using LSD’ s
post hoc multiple comparisons. The longitudinal quantification data
were analyzed using ‘ANOVA of Repeated Measures’ with body
weight as a covariant variable for eliminating its influence on the
measurement results, using LSD’ s post hoc multiple comparisons.
The in vitro data was evaluated by ANOVA, using LSD’ s post hoc
multiple comparisons. All statistical analysis was performed using
SPSS 10.0. Statistical significance for compaison was set at P,0.05.
Results
Prevention Efficacy and Safety Evaluation
Neither organ bleeding nor death was found in any group
throughout the experimental period. Either ALT or AST, the
index of hepatocyte injury, did not significantly change from
baseline among all the groups except moderate increase at 1 week
in the CON group throughout the experimental period
(Figure 2A–B). ON lesion was not found until week 2 post
induction in each group. ON lesion was histopathologically
characterized with trabecular bone containing considerable empty
lacunae (Figure 3A, 3B and 3C). The ON Incidence was 93% (15/
16) in the CON group, 56% (9/16) in the L-EF group, 13% (2/16)
in the M-EF group and 6% (1/16) in the H-EF group, respectively.
Fisher’s exact probability test showed that the ON incidence in the
L-EF, M-EF and H-EF group was significantly lower than that in
the CON group (P,0.05 for all). The ON Incidence in the M-EF
and H-EF group was significantly lower than that in the L-EF
group (P,0.05 for both), whereas no difference in the ON
Incidence was found between the M-EF and H-EF group
(P.0.05). There was no significant difference in the ON Extent
among the CON group (2.860.8), L-EF group (2.560.6), M-EF
group (2.460.7) and H-EF group (2.660.5) (Figure 3D and 3E).
Effect on Pathogenic Events Involving Intravascular/
Extravascular Abnormalities
Intravascular histopathology and its contributive events: Histo-
pathologically, thrombi were predominantly found in small
marrow vessels in the CON group since week 1 post induction
(Figure 3B). The Thrombotic Vessel Counts in the CON group
increased to peak level at week 1 post induciton, and then
maintained until week 2 post indcution. There was a significant
difference in the changing pattern between the CON group and
the three EF groups. The increased Thrombotic Vessel Counts in
the CON group were either attenuated in the L-EF group or
prevented in both the M-EF and H-EF group throughout the
experimental period. Fisher’s exact probability test showed that
the order of the Thrombotic Vessel Counts at week 1 post
indctuion was smilar to those at week 2 post indctuion, i.e.
CON.L-EF.M-EF=H-EF (Figure 3F). Mechanistically, TM in
the CON group presented a significant increase at week 1 post
induction (P=0.000), then declined toward baseline. There was a
significant difference in the changing pattern between the CON
group and the three EF groups (P,0.05 for L-EF vs CON,
P,0.01 for both M-EF vs CON and H-EF vs CON). Especially,
the significant increase in TM in the CON group was either
attenuated in the L-EF group or almost prevented in both the M-
EF and H-EF group at week 1 post induction (Figure 2C).
Extravascular histopathology and its contributive events:
Histopathologically, marrow was predominantly occupied by
numerous fat cells in the CON group after induction (Figure 3C).
The Fat Cell Area Fraction in the CON group increased
signficantly at week 1 post induciton, and then maintained until
week 2 post indcution (P,0.05 for both). There was a significant
difference in the changing pattern between the CON group and
the three EF groups. The significantly increased Fat Cell Area
Fraction in the CON group was either attenuated in the L-EF
group or prevented in both the M-EF and H-EF group throughout
the experimental period. Fisher’s exact probability test showed
that the order of the Fat Cell Area Fraction at week 1 post
indctuion was smilar to that at week 2 post indctuion, i.e.
CON.L-EF.M-EF=H-EF (Figure 3G). Mechanistically, Adi-
pocyte Positive Colonies in the CON group increased significantly
at week 1 post induction (P,0.01), then moderately restored
toward baseline. There was a significant difference in the changing
pattern between the CON group and the three EF groups (P,0.05
for L-EF vs CON, P,0.01 for both M-EF vs CON and H-EF vs
CON). Especially, the significant increase in the Adipocyte
Positive Colonies was either attenuated in the L-EF group or
almost prevented in both the M-EF and H-EF group at week 1
post induction (Figure 2D).
Effect on Pathophysiology Reflecting Abnormality in
Vascular Perfusion Function
The PEP in the CON group decreased significantly at week 1
post-induction (P,0.01), then significantly increased over the
baseline at week 2 post-induction (P,0.01). There was a
significant difference in the changing pattern of the PEP over
time between the CON group and three EF groups (P,0.01 for L-
EF vs CON, P,0.01 for both M-EF vs CON and H-EF vs CON).
In particular, the significant decrease in the PEP in the CON
group was attenuated in the L-EF group and almost prevented in
both the M-EF and H-EF group at week 1 post induction
(Figure 2E).
Identification of Prototype and Metabolite of EF in Serum
A total ion chromatogram in full scan mode was generated by
HPLC/UV/MS/MS. Compared with the blank sera from the
CON group, it was obviously that there was a peak in 38.1 min in
the sera from three EF groups (Figure 4A,B), which was
structurally identified as Icaritin with the following steps. 1) Under
the same mobile phase elution, the standard Icaritin was also
washed out with the same retention time (Figure 4C); 2) 391 (m/z
Epimedium Prevents ON
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6419Figure 2. Hematology/cytology/MRI data analysis. There was no significant change from baseline in ALT (A) and AST (B) when compared to
the CON group. Significantly increased TM (C) from baseline in the CON group was attenuated in the L-EF group or prevented in both the M-EF and
H-EF group at week 1 post induction, and adipocyte positive colonies (D) in the CON group were attenuated in the L-EF group or prevented in both
the M-EF and H-EF group after induction. In addition, the significantly decreased PEP (E) from baseline in the CON group was attenuated in the L-EF
group or prevented in both the M-EF and H-EF group at week 1 post induction. Note: *P ,0.05 for comparison with CON; # P,0.05 for comparison
with baseline.N CON group; X L-EF group; & M-EF group; m H-EF group.
doi:10.1371/journal.pone.0006419.g002
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6419Figure 3. Key characteristics for histopathological identification and histopathological data analysis. ON lesion was found with
trabecular bone containing considerable empty lacunae and lack of marrow cells (B) when compared to normal bone (A).I nO N
+ rabbits, thrombi
were predominantly found in small marrow vessels with lack of angiographic particles (C), and marrow was predominantly occupied by a numerous
fat cells (B, C). (D) Incidence of ON in each group: CON (13/14, 93%), L-EF (9/16, 56%), M-EF (2/16, 13%), H-EF (1/16, 6%). (E) There was no significant
difference in ON Extent among all the groups. (F) Thrombotic Vessel Counts, and (G) Fat Cell Area Fraction presented similarities in changing patter
over time, i.e. either attenuated in the L-EF group or prevented in both the M-EF and H-EF group when compared to that in the CON group. Note:
Arrow pointed particle was angiographic substance during microCT-based angiography (data not shown).N CON group; X L-EF group; & M-EF
group; m H-EF group; * P,0.05
doi:10.1371/journal.pone.0006419.g003
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PLoS ONE | www.plosone.org 6 July 2009 | Volume 4 | Issue 7 | e6419Figure 4. A total ion chromatogram in full scan mode generated by HPLC/UV/MS/MS. (A),(B) Compared with the blank sera, a peak
shown in 38.1 min in the sera from L-EF, M-EF and H-EF group. (C) HPLC profile of standard Icaritin. (D) 391 (m/z [M+Na]
+) for Icaritin selected for the
subsequent selected ion chromatography (SIC), with a peak at 38.1 min. (E) The +MS showed the mass weight by 391 ion (m/z [M+Na]
+) and the
absence of 56 exhibited the existence of prenyl in the +MS
2 chromatography. (F) Epimedium-derived flavonoids with common stem nuclei
intestinally metabolized to Icaritin.
doi:10.1371/journal.pone.0006419.g004
Epimedium Prevents ON
PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6419[M+Na]
+) for Icaritin was selected for the subsequent selected ion
chromatography (SIC), and a peak at 38.1 min was also present
(Figure 4D); 3) Further, the +MS showed the mass weight by 391
ion (m/z [M+Na]
+) and the absence of 56 exhibited the existence
of prenyl in the +MS
2 chromatography (Figure 4E), which firmly
confirmed the structure of Icaritin. In addition, those seven
flavonoid compounds were found not only absent in the HPLC
profiles, but also not shown in the SIC profiles according to their
mass weight.
Effects of Icaritin (Serum Metabolite of EF) and seven
prototype flavonoids in EF on Both Endothelial Cell
Damage and Preadipocyte Lipid Deposition in vitro
In endothelial cell damage model, supernate soluble TM in
endotoxin induction group was significantly higher than that in the
control group (P,0.05), whereas Icaritin dose-dependently
lowered supernate soluble TM at three different dosages when
compared to the induction group (P,0.05 for all) (Figure 5A), but
the seven prototype flavonoids in EF at the concentration of
10
214 M could not decrease the supernate soluble TM compared
to the induction group (Figure 5C). In preadipocyte lipid
deposition model, optical density in destained Oil Red O Staining
in the induction group was significantly higher than that in the
control group (P,0.05), whereas Icaritin dose-dependently
lowered optical density at three different dosages when compared
to the induction group (P,0.05 for all) (Figure 5B), but no
differences were shown between the seven prototype flavonoids in
EF at the concentration of 10
214 M and the induction group in
optical density in Oil Red O staining (Figure 5C).
Discussion
This was the first experimental study which demonstrated dose-
dependent effect of Epimedium-derived flavonoids with common
stem nuclear on inhibition of both intravascular thrombosis and
extravascular lipid-deposition and accordingly reducing incidence
of steroid-associated ON in rabbits.
Dose-dependent Influence on Reducing Risk of Steroid-
associated ON
The results of the calculated ON incidence indicated that EF
was a potential phytotherapeutic agent for reducing risk of steroid-
associated ON in a dose-dependent manner, which also provided
experimental explanation for the previous clinical findings that
ON prevalence was lower in patients recovered from SARS
frequently prescribed with crude extract of Epimedium during their
rehabilitation in southern China than those seldom prescribed
with crude extract of Epimedium in northern China [9–11,24]. On
the other hand, no significant difference in the ON Extent among
all the groups suggested a threshold beyond which development of
ON lesion was initiated, which was consistent with the findings
reported in our published study [12] and by other’s experimental
study [8]. It also indicated that once the threshold was reached,
the prevention with EF had little effect on development of ON.
Vascular toxicity, e.g. organ bleeding, is a major concern on
administration of a combination of an anticoagulant and a lipid-
lowering agent in prevention of steroid-induced ON development
even though such pharmaceutical combination strategy was
experimentally confirmed for their efficacy [8]. The available
experimental records of the present study indicated that EF was
safe for vascular system throughout the observation period, which
was evidenced by neither bleeding nor bleeding-related death
under the employed three dosage regimens. In addition, hepatic
safety is also an important concern. In the present study, a
moderate (non-significant) increase in ALT or AST (hepatocyte
injure index) was found in the CON group after induction with a
combination of endotoxin and steroid. This is understandable
since endotoxin has been reported to be detrimental to hepatocyte
and steroid has been believed to lead to elevated lipogenesis and
then overburden of lipid transportation of hepatocyte [4]. Further,
ALT or AST did not significantly change from baseline when
compared to the CON group among the three dosage groups,
indicating hepatic safety of EF.
Dose-dependent Influence on Inhibiting Extravascular
Events
Histopathological examination suggested that EF was able to
dose-dependently inhibit extravascular lipid deposition, which was
evidenced by a significant increase in Fat Cell Area Fraction in the
CON group while attenuated in the L-EF group or prevented in
both the M-EF and H-EF group.
As to pathogenesis of extravascular lipid deposition during early
stage of steroid-associated ON development, elevated adipogenesis
was an important extravascular contribution event [25]. In terms
of evaluation on condition of adipogenesis for this study, a high
level of Adipocyte Positive Colonies (an adipogenic potential
index) was considered to reflect excessive adipogenesis. In the
present study, the results showed that excessive adipogenesis
occurred at early stage of steroid-associated ON development,
which was evidenced by the significantly increased level of
Adipocyte Positive Colonies in the CON group at week 1 post
induction. The experimental findings were also consistent with our
previously published studies [7,12]. Further, the results also
indicated that EF was able to dose-dependently counteract
elevated adipogenesis, which was evidenced by the findings that
the significant increase in Adipocyte Positive Colonies in the CON
group was attenuated in the L-EF group or almost prevented in
both the M-EF and H-EF group at week 1 post induction.
Dose-dependent Influence on Inhibiting Intravascular
Events
The results suggested that EF was able to dose-dependently
inhibit intravascular thrombosis, which was evidenced by the
findings that the increased Thrombotic Vessel Counts in the CON
group were attenuated in the L-EF group or prevented in both the
M-EF and H-EF group throughout the experimental period.
As to pathogenesis of intravascular thrombosis, endothelium
injury is recognized as an important initial contribution event in
vascular diseases. Soluble TM in plasma is an index of endothelial
injury. Endothelium TM is a cell surface glycoprotein that is
primarily expressed in endothelial cells and, along with protein C,
plays a role in counteracting both hypercoagulation and
hypofibrinolysis after endothelial cell injury, which maintain
balance between coagulation and fibrinolysis [26]. In the present
study, a significant increase in TM in the CON group at week 1
post induction was found, which was also corresponding to a
published study [27]. Further, our results also indicated that EF
was able to dose-dependently protect endothelium from injuring,
which was evidenced by the fact that the significantly increased
TM in the CON group was either attenuated in the L-EF group or
almost prevented in both the M-EF and H-EF group at week 1
post induction.
Dose-dependent Influence on Preventing Decrease in
Perfusion Function
A general consensus is that local vascular supply is the key to
provide oxygen and nutrient to meet requirement of homeostatic
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6419Figure 5. Supernate soluble TM in endotoxin induction group (A) and optical density in destained oil red O staining in steroid
induction group (B) was significantly higher than the corresponding control group, respectively, whereas Icaritin dose-
dependently lowered supernate soluble TM (A) and optical density in destained oil red O staining (B) when compared to the
corresponding induction group, respectively. However, no differences were found between the seven parent flavonoids in EF at the
concentration of 10
214 M and corresponding induction group both in supernate soluble TM (C) and optical density in destained oil red O staining
(D). Note: *P ,0.05 for comparison with the induction group. # P,0.05 for comparison with the low dose group.
doi:10.1371/journal.pone.0006419.g005
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dynamic contrast-enhanced MRI, may reflect ‘vascular quantity’
for vascular supply. In the present study, the significantly
decreased PEP in the CON group at week 1 post-induction
indicated insufficient vascular perfusion at an early stage. The
results also indicated that EF was able to dose-dependently
maintain ‘vascular quantity’ at an early stage, as evidenced by the
findings, i.e. the significantly decreased PEP in the CON group
was attenuated in the L-EF group and almost prevented in the H-
EF group at week 1 post-induction.
EF Exerted Prevention Effects not via Their Direct Action
on Potential Target Cells
EF mainly consist of seven flavonoid glycosides with common
stem nuclear. The question is how does EF exert their effect on
cellular target? On one hand, Icaritin as a major intestinal
metabolite, in the present study, was detected in the sera of the
rabbits treated with EF, whereas those seven flavonoid glycosides
were not detected, indicating that those seven flavonoid molecules
in EF were intestinally metabolized to Icaritin (Figure 4F). This
finding was also consistent with recent studies that Icaritin was the
primary intestinal metabolite of prenyl flavonoids from Epimedium
[29]. On the other hand, our unpublished data demonstrated
neither measurable protection effect of EF on endotoxin-induced
damage of human umbilical vein endothelial cell, nor measurable
inhibition effect of EF on steroid-induced lipid deposition of 3T3-
L1 Preadipocyte (data not shown). Further, the in vitro data from
human umbilical vein endothelial cell model in the present study
showed dose-dependent measurable protection effect of Icaritin on
endotoxin-induced damage, which was evidenced by dose-
dependently lowed supernate soluble TM in the Icaritin groups
at three different dosages as compared to the induction group,
however, no differences were found between the seven parent
flavonoids in EF and the induction group in the supernate soluble
TM. In addition, the in vitro data from 3T3-L1 Preadipocyte
model in the present study showed dose-dependent measurable
inhibition effect of Icaritin on steroid-induced lipid deposition,
which was evidenced by dose-dependently lowed oil red O staining
in the Icaritin groups at three different dosages as compared to the
control group, but no differences were found between the seven
flavonoids in EF and the induction group in the oil red O staining.
The above two evidences were consistent with the HPLC/UV/
MS/MS findings in study I, suggesting that EF compounds
exerted their prevention effects not via direct action by themselves
on potential cellular targets. In addition, our recently published
animal study further demonstrated that Icaritin, the metabolite of
EF, inhibited both thrombosis and lipid-deposition for reducing
incidence of steroid-associated ON in a dose-dependent manner,
implying that Icaritin might be a bioactive molecule served as
common substance basis of those seven flavonoid glycosides with
common stem nuclear in EF, though we have no sufficient
evidence to conclude that Icaritin found in serum after EF
administration was indeed causing the observed prevention effects
of EF [16].
In the future, experimental study using steroid-associated ON
model should be designed to test the hypothesis that EF inhibit
both thrombosis and lipid-deposition for reducing incidence of
steroid-associated osteonecrosis mainly via their common metab-
olite Icaritin. Glycosidase was thought to be one of the main
enzymes to hydrolyze flavonoid glycosides to their corresponding
aglycone in the intestinal, and gluconolactone, a broad specificity
glycosidase inhibitor, can cause limited hydrolysis of flavonoid
glycosides [30]. Thus, gluconolactone could be employed to limit
the hydrolysis of EF, and as a result, prevent the formation of
Icaritin from EF to see if the EF could reduce incidence of steroid-
associated osteonecrosis with the existence of gluconolactone. If
the hypothesis would be confirmed it will definitively not only
facilitate understanding the basic biological sciences of chemistry
metabolism of multi-component EF, but also help further explore
molecular mechanism of EF for reducing risk of steroid-associated
ON. Furthermore, a novel small molecule Icaritin would emerge
into effective prevention of steroid-associated ON.
Conclusion
Constitutional EF compounds exerted dose-dependent effect on
inhibition of both thrombosis and lipid-deposition and accordingly
reducing incidence of steroid-associated ON in rabbits, which was
not via the direct action by themselves on potential cellular targets.
The underlying mechanism could be explained by their counter-
action effects on endothelium injury and excessive adipogenesis.
These findings encourage designing clinical trials to investigate
potential of EF in prevention of steroid-associated ON.
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